Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor

Ads

You May Also Like

CytomX Therapeutics Announces Third Quarter 2018 Financial Results

ESMO Presentations Support CX-072 Product Profile and Probody™ Proof-of-Concept  Advancement of Clinical Stage Probody ...

Horizon Pharma plc to Participate in Investor Conferences in November

DUBLIN, Ireland, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

Arcturus Therapeutics to Present at October Investor Conferences

SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a ...